The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AIPAC (Active Immunotherapy PAClitaxel): A randomized, double blind, placebo controlled, multinational phase IIb trial evaluating the efficacy of eftilagimod alpha (a soluble LAG-3 fusion protein) in combination with paclitaxel in hormone receptor positive metastatic breast cancer.
 
Luc Dirix
No Relationships to Disclose
 
A. Jager
No Relationships to Disclose
 
Frederik Marme
No Relationships to Disclose
 
Etienne Brain
Honoraria - AstraZeneca; Janssen; Pfizer; Roche; Roche; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Celgene; Clinigen Group; Hospira; OBI Pharma; Pfizer; Puma Biotechnology; Puma Biotechnology; Puma Biotechnology
Research Funding - Amgen (Inst); HalioDx (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Mylan; Pfizer; Pfizer; Pierre Fabre; Roche; Roche
 
Anne Caroline Armstrong
No Relationships to Disclose
 
Sergiusz Nawrocki
No Relationships to Disclose
 
Frederic Triebel
Employment - Immutep
Stock and Other Ownership Interests - Immutep
Patents, Royalties, Other Intellectual Property - Immutep